Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease

Advanced fibrosis is associated with end-stage liver disease (ESLD) and mortality in NAFLD. As treatments specifically targeted at NAFLD are lacking, patient management focuses on surveillance for early detection of complications related to end-stage liver disease. Although current and emerging diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruneau, Lina, Kechagias, Stergios, Sandström, Per, Ekstedt, Mattias, Henriksson, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289790/
https://www.ncbi.nlm.nih.gov/pubmed/37347223
http://dx.doi.org/10.1097/HC9.0000000000000191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289790/
https://www.ncbi.nlm.nih.gov/pubmed/37347223
http://dx.doi.org/10.1097/HC9.0000000000000191

Ejemplares similares